Victor P Gazivoda1, Mudathir Ibrahim1, Aaron Kangas-Dick1, Arony Sun1, Michael Silver2, Ory Wiesel1,3. 1. Department of Surgery, 2042Maimonides Medical Center, Brooklyn, NY, USA. 2. Division of Biostatistics, 2042Maimonides Medical Center, Brooklyn, NY, USA. 3. Division of Thoracic Surgery, 2042Maimonides Medical Center, Brooklyn, NY, USA.
Abstract
BACKGROUND: Pneumomediastinum and pneumothorax are complications which may be associated with barotrauma in mechanically ventilated patients. The current literature demonstrates unclear outcomes regarding barotrauma in critically ill patients with severe COVID-19. The purpose of this study was to examine the incidence of barotrauma in patients with severe COVID-19 pneumonia and its influence on survival. STUDY DESIGN AND METHODS: A retrospective cohort study was performed from March 18, 2020 to May 5, 2020, with follow-up through June 18, 2020, encompassing critically ill intubated patients admitted for COVID-19 pneumonia at an academic tertiary care hospital in Brooklyn, New York. Critically ill patients with pneumomediastinum, pneumothorax, or both (n = 75) were compared to those without evidence of barotrauma (n = 206). Clinical characteristics and short-term patient outcomes were analyzed. RESULTS: Barotrauma occurred in 75/281 (26.7%) of included patients. On multivariable analysis, factors associated with increased 30-day mortality were elevated age (HR 1.015 [95% CI 1.004-1.027], P = 0.006), barotrauma (1.417 [1.040-1.931], P = 0.027), and renal dysfunction (1.602 [1.055-2.432], P = 0.027). Protective factors were administration of remdesivir (0.479 [0.321-0.714], P < 0.001) and receipt of steroids (0.488 [0.370-0.643], P < 0.001). CONCLUSION: Barotrauma occurred at high rates in intubated critically ill patients with COVID-19 pneumonia and was found to be an independent risk factor for 30-day mortality.
BACKGROUND: Pneumomediastinum and pneumothorax are complications which may be associated with barotrauma in mechanically ventilated patients. The current literature demonstrates unclear outcomes regarding barotrauma in critically ill patients with severe COVID-19. The purpose of this study was to examine the incidence of barotrauma in patients with severe COVID-19 pneumonia and its influence on survival. STUDY DESIGN AND METHODS: A retrospective cohort study was performed from March 18, 2020 to May 5, 2020, with follow-up through June 18, 2020, encompassing critically ill intubated patients admitted for COVID-19 pneumonia at an academic tertiary care hospital in Brooklyn, New York. Critically ill patients with pneumomediastinum, pneumothorax, or both (n = 75) were compared to those without evidence of barotrauma (n = 206). Clinical characteristics and short-term patient outcomes were analyzed. RESULTS: Barotrauma occurred in 75/281 (26.7%) of included patients. On multivariable analysis, factors associated with increased 30-day mortality were elevated age (HR 1.015 [95% CI 1.004-1.027], P = 0.006), barotrauma (1.417 [1.040-1.931], P = 0.027), and renal dysfunction (1.602 [1.055-2.432], P = 0.027). Protective factors were administration of remdesivir (0.479 [0.321-0.714], P < 0.001) and receipt of steroids (0.488 [0.370-0.643], P < 0.001). CONCLUSION: Barotrauma occurred at high rates in intubated critically ill patients with COVID-19 pneumonia and was found to be an independent risk factor for 30-day mortality.
Authors: Massimiliano Greco; Thomas De Corte; Ari Ercole; Massimo Antonelli; Elie Azoulay; Giuseppe Citerio; Andy Conway Morris; Gennaro De Pascale; Frantisek Duska; Paul Elbers; Sharon Einav; Lui Forni; Laura Galarza; Armand R J Girbes; Giacomo Grasselli; Vitaly Gusarov; Alasdair Jubb; Jozef Kesecioglu; Andrea Lavinio; Maria Cruz Martin Delgado; Johannes Mellinghoff; Sheila Nainan Myatra; Marlies Ostermann; Mariangela Pellegrini; Pedro Povoa; Stefan J Schaller; Jean-Louis Teboul; Adrian Wong; Jan J De Waele; Maurizio Cecconi Journal: Intensive Care Med Date: 2022-05-21 Impact factor: 41.787
Authors: Rohit Baslas; Dorina-Gabriela Condurache; Ambikesh Jayal; Matthew Colquhoun; Jacob Frederik de Wolff Journal: Postgrad Med J Date: 2022-04-15 Impact factor: 4.973
Authors: Penny Andrews; Joseph Shiber; Maria Madden; Gary F Nieman; Luigi Camporota; Nader M Habashi Journal: Front Physiol Date: 2022-07-25 Impact factor: 4.755